论文部分内容阅读
目的:分析中西药联合治疗小儿支气管肺炎的疗效。方法:选取2015年1月至2016年6月中山大学附属第三医院粤东医院进行治疗的小儿支气管肺炎82例患儿作为分组观察对象,将其按照入院顺序进行分组,分为西药组和联合组,各41例。西药组患儿给予阿奇霉素治疗,联合组患儿则使用阿奇霉素联合中药方剂进行治疗,观察两组患儿的症状改善时间、治疗总有效率、不良反应发生情况等指标。结果:联合组患儿的发热、咳嗽、肺部啰音等症状改善时间明显短于西药组,差异具有统计学意义(P<0.05)。西药组治疗总有效率为80.49%,联合组总有效率为97.56%,联合组明显优于西药组,组间比较,差异具有统计学意义(P<0.05)。西药组不良反应发生率为7.32%,联合组不良反应发生率为4.88%,差异无统计学意义(P>0.05)。结论:针对小儿支气管肺炎使用中西药联合治疗可有效缩短临床症状改善时间,提高治疗总有效率,安全用药价值较高。
Objective: To analyze the curative effect of combined treatment of Chinese and western medicine on bronchopneumonia in children. Methods: From January 2015 to June 2016, 82 children with bronchial pneumonia treated in Yue Dong Hospital of the Third Affiliated Hospital of Sun Yat-sen University were enrolled in this study. The children were divided into two groups according to admission sequence: Western medicine group and union group Group, 41 cases each. The children in the western medicine group were treated with azithromycin, while the children in the combined group were treated with azithromycin combined with traditional Chinese medicine. The improvement time, the total effective rate and the adverse reactions of the two groups were observed. Results: The improvement of fever, cough, pulmonary rales and other symptoms in children in combination group was significantly shorter than that in western medicine group (P <0.05). The total effective rate in the western medicine group was 80.49%, and the total effective rate in the combined group was 97.56%. The combined group was obviously superior to the Western medicine group. The difference was statistically significant (P <0.05). The incidence of adverse reactions in the western medicine group was 7.32%, and the incidence of adverse reactions in the combination group was 4.88%, with no significant difference (P> 0.05). Conclusion: The combination of Chinese and Western medicine for children with bronchopneumonia can shorten the time to improve clinical symptoms and improve the total effective rate, and the value of safe medication is high.